| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/18/2004 | US6737514 Compositions and methods for the therapy and diagnosis of lung cancer |
| 05/18/2004 | US6737513 Macrophage derived chemokine (MDC) and chemokine analogs and assay to identify modulators of MDC activity, and therapeutic uses for same |
| 05/18/2004 | US6737511 With two domains that target cell and modify apoptotic response |
| 05/18/2004 | US6737510 Alzheimer's disease secretase, APP substrates therefor, and uses thereof |
| 05/18/2004 | US6737509 For treating diabetes using insulin homolog polypeptide |
| 05/18/2004 | US6737508 DNA sequences from staphylococus aureus bacteriophages 3A, 77, and 96 that encode anti-microbial polypeptides |
| 05/18/2004 | US6737507 Antiangiogenic peptides and compositions thereof |
| 05/18/2004 | US6737413 SOX-9 gene and protein and use in the regeneration of bone or cartilage |
| 05/18/2004 | US6737407 Treatment of obesity |
| 05/18/2004 | US6737406 Cryptic peptides and method for their identification |
| 05/18/2004 | US6737404 Wound healing agents, antiulcer agents, vision defects |
| 05/18/2004 | US6737402 Supercharged zinc fetuin; incubating fetuin with a chelating agent, especially edta; isolating naked fetuin; incubating the naked fetuin with zinc acetate |
| 05/18/2004 | US6737398 Administering tumor necrosis factor-alpha directly to lung tissue |
| 05/18/2004 | US6737273 Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 05/18/2004 | US6737267 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 05/18/2004 | US6737261 Isolated nucleic acid molecules encoding human lanosterol synthase proteins, and related products and processes |
| 05/18/2004 | US6737252 Chemokines and 7 transmembrane receptors from mammals, reagents related thereto, including purified proteins, specific antibodies, and nucleic acids encoding the chemokines and receptors are disclosed. methods of using the |
| 05/18/2004 | US6737251 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 05/18/2004 | US6737250 Plasmid for use in the generation of genetically engineered amino acid sequences |
| 05/18/2004 | US6737248 Apparatus for use in the detection of bacterial infections |
| 05/18/2004 | US6737241 Methods for screening for transdominant intracellular effector peptides and RNA molecules |
| 05/18/2004 | US6737234 Generating a mutant adenovirus characterized by a receptor binding affinity which is significantly weakened for card1 (catalyzed reporter deposition) relative to wild-type adenovirus |
| 05/18/2004 | US6737233 Method for preparing HCV E2 binding protein |
| 05/18/2004 | US6737232 IAPs associated cell cycle proteins, compositions and methods of use |
| 05/18/2004 | US6737086 For accelerating and amplifying the synthesis of thermal shock proteins of cells of living beings |
| 05/18/2004 | US6737074 Cells in a culture medium bind to fibrin microbeads which are biologically active and comprise very crosslinked fibrin(ogen); transplanting; engineering tissue by applying to a prosthesis; separating cells; wound healing agents |
| 05/18/2004 | US6737067 Composition comprising purified recombinant trimer of hiv gp160 which binds to cd4, binds to anti-gp120 antibody capable of neutralizing hiv infection of cells in vitro, binds to anti-gp41 antibody, and has no inter-chain disulfide bridges |
| 05/18/2004 | US6737064 Antitumor agents |
| 05/18/2004 | US6737063 Immunological polypeptides; vaccine against gramnegative bacteria |
| 05/18/2004 | US6737062 Immunogenic compositions |
| 05/18/2004 | US6737058 Methods for inhibiting endothelial cell and fibrinogen mediated inflammation using fibrinogen specific antibodies |
| 05/18/2004 | US6737057 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 05/18/2004 | US6737054 Myocardial grafts and cellular compositions useful for same |
| 05/18/2004 | US6737052 Induction of programmed cell death by N5 gene |
| 05/18/2004 | CA2343719C New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 05/18/2004 | CA2343715C New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 05/18/2004 | CA2248139C Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 05/18/2004 | CA2042945C Protein purification method |
| 05/13/2004 | WO2004040311A1 Means and methods for diagnosing a treponema infection |
| 05/13/2004 | WO2004040310A1 Means and method for diagnosing a treponema infection |
| 05/13/2004 | WO2004040262A2 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/13/2004 | WO2004040000A2 G protein coupled receptors and uses thereof |
| 05/13/2004 | WO2004039999A2 Essential dna enclosed proteins of drosphophilia melanogaster |
| 05/13/2004 | WO2004039996A1 Mthod for producing recombinant human interferon alpha 2b polypeptide in pichia pastoris |
| 05/13/2004 | WO2004039988A1 Ppr peptide sequences capable of restoring male fertility of plants bearing a male sterility-inducing cytoplasm |
| 05/13/2004 | WO2004039981A1 Membrane protein originating in mast cells |
| 05/13/2004 | WO2004039980A1 Agents modulating mal activity |
| 05/13/2004 | WO2004039979A1 Means and methods for diagnosing and treating idiopathic generalized epilepsy (ige) |
| 05/13/2004 | WO2004039978A2 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/13/2004 | WO2004039974A1 Novel protein and dna thereof |
| 05/13/2004 | WO2004039972A1 H17t213-transgenic animal, novel h17t213 protein and dna thereof |
| 05/13/2004 | WO2004039958A2 Lutzomyia longipalpis polypeptides and methods of use |
| 05/13/2004 | WO2004039956A2 Compositions and methods for the treatment of immune related diseases |
| 05/13/2004 | WO2004039955A2 Modulators of angiogenesis and tumorigenesis |
| 05/13/2004 | WO2004039954A2 Type 2 diabetes mellitus genes |
| 05/13/2004 | WO2004039951A2 Il-1 receptor based antagonists and methods of making and using |
| 05/13/2004 | WO2004039950A2 Activation of hcv-specific cells |
| 05/13/2004 | WO2004039948A2 Actriib fusion polypeptides and uses therefor |
| 05/13/2004 | WO2004039945A2 Preventive and therapeutic aids vaccines |
| 05/13/2004 | WO2004039943A2 Human genes and gene expression products isolated from human prostate |
| 05/13/2004 | WO2004039942A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 05/13/2004 | WO2004039940A2 Polynucleotide encoding novel human g-protein coupled receptors, and splice variants thereof |
| 05/13/2004 | WO2004039846A1 Advanced cell-transducing transport domain-target protein-transport domain fusion protein and uses thereof |
| 05/13/2004 | WO2004039841A2 Trimeric binding proteins for trimeric cytokines |
| 05/13/2004 | WO2004039840A1 Chimeric cytoplasmic signalling molecules |
| 05/13/2004 | WO2004039839A2 Modified voltage-gated calcium channels |
| 05/13/2004 | WO2004039838A1 Crystals of insulin analogues and method for the production thereof |
| 05/13/2004 | WO2004039837A2 Crh responsive genes in cns |
| 05/13/2004 | WO2004039836A1 Soluble truncated polypeptides of the nogo-a protein |
| 05/13/2004 | WO2004039835A2 Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone |
| 05/13/2004 | WO2004039834A2 Recombinant protein variants |
| 05/13/2004 | WO2004039833A1 Composition for the treatment of infection by flaviviridae viruses |
| 05/13/2004 | WO2004039832A2 Leptin-related peptides |
| 05/13/2004 | WO2004039407A1 Apoptosis inducer |
| 05/13/2004 | WO2004039400A2 Bhv5 mutants |
| 05/13/2004 | WO2004039394A1 Novel composition and methods for the treatment of immune related diseases |
| 05/13/2004 | WO2004039382A1 Enhanced production of clotting factors by cryoprecipitation |
| 05/13/2004 | WO2004039334A2 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING |
| 05/13/2004 | WO2004039333A2 ANTIGENIC gp 100 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME |
| 05/13/2004 | WO2004039324A2 Anti-hiv (sl9) compounds |
| 05/13/2004 | WO2004039319A2 Novel human polypeptides encoded by polynucleotides |
| 05/13/2004 | WO2004039309A2 Dc-sign isoforms, related compositions and methods for their use in disease therapy |
| 05/13/2004 | WO2004039307A2 Methods and compositions for diagnosing and treating companion animal cancer |
| 05/13/2004 | WO2004039244A2 Methods and kits for diagnosing tumorigenicity |
| 05/13/2004 | WO2004029135A3 Gluten biopolymers |
| 05/13/2004 | WO2004029077A3 Method for producing acylated peptides |
| 05/13/2004 | WO2004029076A3 Purification process comprising microfiltration at elevated temperatures |
| 05/13/2004 | WO2004020609A9 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
| 05/13/2004 | WO2004014299A3 Antisense modulation of resistin expression |
| 05/13/2004 | WO2004005469A3 Peptides from the e2, e6 and e7 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other cancers |
| 05/13/2004 | WO2004000415A3 Tissue reconstruction and regeneration |
| 05/13/2004 | WO2003093453A3 Bacillus licheniformis mutant host cell |
| 05/13/2004 | WO2003077831A3 Compositions and methods for treating mdma-induced toxicity |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | WO2003068163A3 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
| 05/13/2004 | WO2003066859A3 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 05/13/2004 | WO2003057892B1 Viruses with enhanced lytic potency |
| 05/13/2004 | WO2003053921A9 Mutant proteinase inhibitors and uses thereof |
| 05/13/2004 | WO2003050256A3 Novel human g-protein coupled receptor, hgprbmy34, and variants and methods of use thereof |
| 05/13/2004 | WO2003050245A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |